Browse > Article
http://dx.doi.org/10.4062/biomolther.2014.102

Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition  

Bae, Ok-Nam (College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University)
Noh, Minsoo (Collge of Pharmacy, Natural Products Research Institute, Seoul National University)
Chun, Young-Jin (College of Pharmacy, Chung-Ang University)
Jeong, Tae Cheon (College of Pharmacy, Yeungnam University)
Publication Information
Biomolecules & Therapeutics / v.23, no.1, 2015 , pp. 12-18 More about this Journal
Abstract
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.
Keywords
Vascular endothelial growth factor (VEGF); Biomarker; Keratinocytic damage; Dermal toxicity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Alitalo, A. K., Proulx, S. T., Karaman, S., Aebischer, D., Martino, S., Jost, M., Schneider, N., Bry, M. and Detmar, M. (2013) VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis. Cancer Res. 73, 4212-4221.   DOI
2 Bernard, F. X., Morel, F., Camus, M., Pedretti, N., Barrault, C., Garnier, J. and Lecron, J. C. (2012) Keratinocytes under fire of proinflammatory cytokines: Bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. J. Allergy (Cairo) 2012, 718725.
3 Ballaun, C., Weninger, W., Uthman, A., Weich, H. and Tschachler, E. (1995) Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol. 104, 7-10.   DOI
4 Bhushan, M., McLaughlin, B., Weiss, J. B. and Griffiths, C. E. (1999) Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br. J. Dermatol. 141, 1054-1060.   DOI
5 Blaudschun, R., Brenneisen, P., Wlaschek, M., Meewes, C. and Scharffetter- Kochanek, K. (2000) The first peak of the UVB irradiationdependent biphasic induction of vascular endothelial growth factor (VEGF) is due to phosphorylation of the epidermal growth factor receptor and independent of autocrine transforming growth factor alpha. FEBS Lett. 474, 195-200.   DOI
6 Brauchle, M., Funk, J. O., Kind, P. and Werner, S. (1996) Ultraviolet B and $H_{2}O_{2}$ are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271, 21793-21797.   DOI
7 Brenneisen, P., Blaudschun, R., Gille, J., Schneider, L., Hinrichs, R., Wlaschek, M., Eming, S. and Scharffetter-Kochanek, K. (2003) Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. Biochem. J. 369, 341-349.   DOI
8 Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F. and van de Water, L. (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379.   DOI
9 Canavese, M., Altruda, F., Ruzicka, T. and Schauber, J. (2010) Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis-- a possible target for novel therapies? J. Dermatol. Sci. 58, 171-176.   DOI
10 Cao, Y., E, G., Wang, E., Pal, K., Dutta, S. K., Bar-Sagi, D. and Mukhopadhyay, D. (2012) VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression. Cancer Res. 72, 3912-3918.   DOI
11 Carmeliet, P. (2000) Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6, 389-395.   DOI
12 Christensen, T. E., Callis, K. P., Papenfuss, J., Hoffman, M. S., Hansen, C. B., Wong, B., Panko, J. M. and Krueger, G. G. (2006) Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes. J. Invest. Dermatol. 126, 2397-2403.   DOI
13 Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G. and Levi, B. Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736-741.   DOI
14 Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. and Siemeister, G. (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 15, 669-676.   DOI
15 Elias, P. M., Arbiser, J., Brown, B. E., Rossiter, H., Man, M. Q., Cerimele, F., Crumrine, D., Gunathilake, R., Choi, E. H., Uchida, Y., Tschachler, E. and Feingold, K. R. (2008) Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am. J. Pathol. 173, 689-699.   DOI
16 Enerback, C. (2011) Soluble biomarkers in psoriasis. Eur. J. Dermatol. 21, 844-850
17 Ferrara, N., Gerber, H. P. and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.   DOI
18 Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.   DOI
19 Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G. and Werner, S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270, 12607-12613.   DOI
20 Geretti, E., Shimizu, A. and Klagsbrun, M. (2008) Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39.   DOI
21 Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J. and Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.   DOI
22 Kakurai, M., Demitsu, T., Umemoto, N., Kobayashi, Y., Inoue-Narita, T., Fujita, N., Ohtsuki, M. and Furukawa, Y. (2009) Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes. Br. J. Dermatol. 161, 1232-1238.   DOI
23 Karkkainen, M. J. and Petrova, T. V. (2000) Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19, 5598-5605.   DOI
24 Kataru, R. P., Jung, K., Jang, C., Yang, H., Schwendener, R. A., Baik, J. E., Han, S. H., Alitalo, K. and Koh, G. Y. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113, 5650-5659.   DOI
25 Kim, H. J. and Kim, T. Y. (2005) Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C. Br. J. Dermatol. 152, 418-425.   DOI
26 Kozlowska, U., Blume-Peytavi, U., Kodelja, V., Sommer, C., Goerdt, S., Jablonska, S. and Orfanos, C. E. (1998) Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology 196, 89-92.   DOI
27 Kubo, A., Nagao, K. and Amagai, M. (2012) Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 122, 440-447.   DOI   ScienceOn
28 Nissen, N. N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L. and DiPietro, L. A. (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152, 1445-1452.
29 Nakai, K., Yoneda, K., Moriue, T., Igarashi, J., Kosaka, H. and Kubota, Y. (2009) HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells. J. Dermatol. Sci. 55, 170-178.   DOI
30 Nielsen, H. J., Christensen, I. J., Svendsen, M. N., Hansen, U., Werther, K., Brunner, N., Petersen, L. J. and Kristensen, J. K. (2002) Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm. Res. 51, 563-567.   DOI
31 Olsson, A. K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371.   DOI
32 Palacio, S., Schmitt, D. and Viac, J. (1997) Contact allergens and sodium lauryl sulphate upregulate vascular endothelial growth factor in normal keratinocytes. Br. J. Dermatol. 137, 540-544.   DOI
33 Quail, D. F. and Joyce, J. A. (2013) Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437.   DOI
34 Rogers, M. S. and D'Amato, R. J. (2006) The effect of genetic diversity on angiogenesis. Exp. Cell Res. 312, 561-574.   DOI
35 Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M. and Carmeliet, P. (2009) Role and therapeutic potential of VEGF in the nervous system. Physiol. Rev. 89, 607-648.   DOI
36 Syed, D. N., Afaq, F. and Mukhtar, H. (2012) Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem. Photobiol. 88, 1184-1190.   DOI
37 Skobe, M., Brown, L. F., Tognazzi, K., Ganju, R. K., Dezube, B. J., Alitalo, K. and Detmar, M. (1999) Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDSassociated Kaposi's sarcoma. J. Invest. Dermatol. 113, 1047-1053.   DOI
38 Suto, K., Yamazaki, Y., Morita, T. and Mizuno, H. (2005) Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J. Biol. Chem. 280, 2126-2131.   DOI
39 Suzuki, T., Hirakawa, S., Shimauchi, T., Ito, T., Sakabe, J., Detmar, M. and Tokura, Y. (2014) VEGF-A promotes IL-17A-producing gammadelta T cell accumulation in mouse skin and serves as a chemotactic factor for plasmacytoid dendritic cells. J. Dermatol. Sci. 74, 116-124.   DOI
40 Takahashi, H. and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond) 109, 227-241.   DOI
41 Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
42 Trompezinski, S., Berthier-Vergnes, O., Denis, A., Schmitt, D. and Viac, J. (2004) Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts. Exp. Dermatol. 13, 98-105.   DOI
43 Detmar, M., Brown, L. F., Berse, B., Jackman, R. W., Elicker, B. M., Dvorak, H. F. and Claffey, K. P. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108, 263-268.   DOI
44 de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N. and Williams, L. T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.   DOI
45 Detmar, M. (1996) Molecular regulation of angiogenesis in the skin. J. Invest. Dermatol. 106, 207-208.   DOI
46 Detmar, M. (2000) The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24 Suppl 1, S78-84.
47 Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B. and Dvorak, H. F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141-1146.   DOI
48 Detmar, M., Brown, L. F., Schon, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P. and Jain, R. K. (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111, 1-6.   DOI
49 Detmar, M., Yeo, K. T., Nagy, J. A., Van de Water, L., Brown, L. F., Berse, B., Elicker, B. M., Ledbetter, S. and Dvorak, H. F. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105, 44-50.   DOI
50 Diaz, B. V., Lenoir, M. C., Ladoux, A., Frelin, C., Demarchez, M. and Michel, S. (2000) Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J. Biol. Chem. 275, 642-650.   DOI
51 Hanel, K. H., Cornelissen C., Luscher, B. and Baron, J. M. (2013) Cytokines and the skin barrier. Int. J. Mol. Sci. 14, 6720-6745.   DOI
52 Gille, J., Reisinger, K., Asbe-Vollkopf, A., Hardt-Weinelt, K. and Kaufmann, R. (2000) Ultraviolet-A-induced transactivation of the vascular endothelial growth factor gene in HaCaT keratinocytes is conveyed by activator protein-2 transcription factor. J. Invest. Dermatol. 115, 30-36.   DOI
53 Gille, J., Swerlick, R. A. and Caughman, S. W. (1997) Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J. 16, 750-759.   DOI
54 Goel, H. L. and Mercurio, A. M. (2013) VEGF targets the tumour cell. Nat. Rev. Cancer 13, 871-882.   DOI
55 Hicklin, D. J. and Ellis, L. M. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23, 1011-1027.   DOI
56 Hirakawa, S., Fujii, S., Kajiya, K., Yano, K. and Detmar, M. (2005) Vascular endothelial growth factor promotes sensitivity to ultraviolet Binduced cutaneous photodamage. Blood 105, 2392-2399.   DOI
57 Huggenberger, R. and Detmar, M. (2011) The cutaneous vascular system in chronic skin inflammation. J. Investig. Dermatol. Symp. Proc. 15, 24-32.   DOI
58 Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K. and Alitalo, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425.   DOI   ScienceOn
59 Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.   DOI
60 Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. and Iruela-Arispe, M. L. (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691.   DOI   ScienceOn
61 Longuet-Perret, I., Schmitt, D. and Viac, J. (1998) Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br. J. Dermatol. 138, 221-224.   DOI
62 Ma, L., Xue, H. B., Guan, X. H., Shu, C. M., Zhang, J. H. and Yu, J. (2014) Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin. Exp. Immunol. 175, 25-31.   DOI
63 Man, X. Y., Yang, X. H., Cai, S. Q., Bu, Z. Y. and Zheng, M. (2008) Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J. Cell. Mol. Med. 12, 649-660.   DOI
64 Man, X. Y., Yang, X. H., Cai, S. Q., Yao, Y. G. and Zheng, M. (2006) Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol. Med. 12, 127-136.
65 Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancerrelated inflammation. Nature 454, 436-444.   DOI
66 Mildner, M., Weninger, W., Trautinger, F., Ban, J. and Tschachler, E. (1999) UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem. Photobiol. 70, 674-679.   DOI
67 Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C. and Roy, S. (2002) Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277, 33284-33290.   DOI
68 Schiefelbein, D., Seitz, O., Goren, I., Dissmann, J. P., Schmidt, H., Bachmann, M., Sader, R., Geisslinger, G., Pfeilschifter, J. and Frank, S. (2008) Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Mol. Pharmacol. 74, 952-963.   DOI
69 Schonthaler, H. B., Huggenberger, R., Wculek, S. K., Detmar, M. and Wagner, E. F. (2009) Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc. Natl. Acad. Sci. U.S.A. 106, 21264-21269.   DOI
70 Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H. and Arbeit, J. M. (2008) HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 111, 3343-3354.   DOI
71 Senger, D. R. (2010) Vascular endothelial growth factor: much more than an angiogenesis factor. Mol. Biol. Cell 21, 377-379.   DOI
72 Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.   DOI
73 Shi, V. Y., Bao, L. and Chan, L. S. (2012) Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4- transgenic mouse model. Microcirculation 19, 567-579.   DOI
74 Wilgus, T. A., Matthies, A. M., Radek, K. A., Dovi, J. V., Burns, A. L., Shankar, R. and DiPietro, L. A. (2005) Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am. J. Pathol. 167, 1257-1266.   DOI
75 Weidemann, A. K., Crawshaw, A. A., Byrne, E. and Young, H. S. (2013) Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin. Cosmet. Investig. Dermatol. 6, 233-244.
76 Weir, L., Robertson, D., Leigh, I. M., Vass, J. K. and Panteleyev, A. A. (2011) Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim. Biophys. Acta 1813, 60-72.   DOI
77 Weninger, W., Uthman, A., Pammer, J., Pichler, A., Ballaun, C., Lang, I. M., Plettenberg, A., Bankl, H. C., Sturzl, M. and Tschachler, E. (1996) Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab. Invest. 75, 647-657.
78 Xia, Y. P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D. and Rudge, J. S. (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102, 161-168.   DOI
79 Yano, K., Brown, L. F. and Detmar, M. (2001) Control of hair growth and follicle size by VEGF-mediated angiogenesis. J. Clin. Invest. 107, 409-417.   DOI
80 Yano, K., Kadoya, K., Kajiya, K., Hong, Y. K. and Detmar, M. (2005) Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br. J. Dermatol. 152, 115-121.   DOI
81 Zhang, Y., Matsuo, H. and Morita, E. (2006) Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch. Dermatol. Res. 297, 425-429.   DOI
82 Young, H. S., Summers, A. M., Read, I. R., Fairhurst, D. A., Plant, D. J., Campalani, E., Smith, C. H., Barker, J. N., Detmar, M. J., Brenchley, P. E. and Griffiths, C. E. (2006) Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J. Invest. Dermatol. 126, 453-459.   DOI   ScienceOn
83 Yu, X. J., Ren, X. H., Xu, Y. H., Chen, L. M., Zhou, C. L., Li and C. Y. (2010) Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway. Neuropeptides 44, 407-411.   DOI
84 Zgraggen, S., Ochsenbein, A. M. and Detmar, M. (2013) An important role of blood and lymphatic vessels in inflammation and allergy. J. Allergy (Cairo) 2013, 672381.
85 Zhu, J. W., Wu, X. J., Lu, Z. F., Luo, D., Cai, S. Q. and Zheng, M. (2013) Role of VEGF receptors in normal and psoriatic human keratinocytes: evidence from irradiation with different UV sources. PLoS One 8, e55463.   DOI
86 Zhu, J. W., Wu, X. J., Luo, D., Lu, Z. F., Cai, S. Q. and Zheng, M. (2012) Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. Int. J. Biochem. Cell Biol. 44, 246-256.   DOI